Effective anti-tumor adoptive immunotherapy: utilization of exogenous IL-2-independent cytotoxic T lymphocyte clones.

Source:http://linkedlifedata.com/resource/pubmed/id/12456594

Download in:

View as

General Info

PMID
12456594